Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.5730
+0.0064 (1.13%)
At close: Dec 19, 2025, 4:00 PM EST
0.5845
+0.0115 (2.01%)
After-hours: Dec 19, 2025, 7:54 PM EST
Immunic Market Cap
Immunic has a market cap or net worth of $68.92 million as of December 19, 2025. Its market cap has decreased by -38.79% in one year.
Market Cap
68.92M
Enterprise Value
34.58M
1-Year Change
-38.79%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $68.92M, a decrease of -71.71%. That is a compound annual growth rate of -17.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 68.92M | -23.49% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | 316.78M | 222.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |